NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

Search

Coloplast A-S (Class B)

Fermé

430 1.9

Résumé

Variation du prix de l'action

24h

Actuel

Min

422.1

Max

434.9

Chiffres clés

By Trading Economics

Revenu

522M

1.4B

Ventes

83M

7B

P/E

Moyenne du Secteur

24.41

66.418

BPA

6.32

Rendement du dividende

5.19

Marge bénéficiaire

19.835

Employés

16,983

EBITDA

309M

2.3B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

5.19%

2.36%

Prochains Résultats

12 mai 2026

Date du Prochain Dividende

20 mai 2026

Date du Prochain Détachement de Dividende

18 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-21B

97B

Ouverture précédente

428.1

Clôture précédente

430

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 avr. 2026, 17:04 UTC

Principaux Mouvements du Marché

FDA Rejects Replimune's Melanoma Drug for a Second Time

11 avr. 2026, 00:00 UTC

Résultats
Acquisitions, Fusions, Rachats

Big Yachts, Big Bucks -- Barrons.com

10 avr. 2026, 21:55 UTC

Acquisitions, Fusions, Rachats

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10 avr. 2026, 21:01 UTC

Résultats

Cango Inc.: Files Annual Report on Form 20-F With SEC

10 avr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10 avr. 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Basic Materials Roundup: Market Talk

10 avr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 avr. 2026, 20:31 UTC

Market Talk

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10 avr. 2026, 20:10 UTC

Acquisitions, Fusions, Rachats

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10 avr. 2026, 19:15 UTC

Market Talk

Global Energy Roundup: Market Talk

10 avr. 2026, 19:15 UTC

Market Talk

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10 avr. 2026, 19:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10 avr. 2026, 19:08 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

10 avr. 2026, 18:38 UTC

Market Talk

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

10 avr. 2026, 18:25 UTC

Market Talk
Principaux Événements d'Actualité

Precious Metals Finish With Weekly Gains -- Market Talk

10 avr. 2026, 18:05 UTC

Market Talk

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

10 avr. 2026, 17:31 UTC

Market Talk
Principaux Événements d'Actualité

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

10 avr. 2026, 17:26 UTC

Résultats

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

10 avr. 2026, 17:10 UTC

Market Talk

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

10 avr. 2026, 17:00 UTC

Principaux Événements d'Actualité

Construction Business Taking a Hit From Iran Conflict -- WSJ

10 avr. 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

10 avr. 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

10 avr. 2026, 16:12 UTC

Résultats

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

10 avr. 2026, 16:11 UTC

Résultats

Partners Group: Traditional Programs Contributed $3.3B

10 avr. 2026, 16:10 UTC

Résultats

Partners Group: $5B of New Commitments Came From Bespoke Solutions

10 avr. 2026, 16:10 UTC

Résultats

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

10 avr. 2026, 16:10 UTC

Résultats

Partners Group 1Q New Client Demand $8.3B

10 avr. 2026, 16:09 UTC

Résultats

Partners Group Continued to See Positive Fundraising Momentum in 1Q

10 avr. 2026, 15:54 UTC

Acquisitions, Fusions, Rachats

Plenitude Completes Acquisition of Acea Energia

10 avr. 2026, 15:38 UTC

Market Talk

Global Energy Roundup: Market Talk

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat